A Meta‐Analysis of Magnetic Resonance Spectroscopy Studies on Glutamatergic Neurometabolite Levels in Major Depressive Disorder
Depression and Anxiety · 2025-01 · 2025 (1)
DOI: 10.1155/da/5180077 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Depression and Anxiety, online erschienen am 01.08.2025. Verfasst von Shiwan Tao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Mental Health Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Major Depressive Disorder, Glutamic Acid, Gyrus Cinguli, Glutamine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Glutamatergic neurometabolite dysregulation has recently garnered attention in the pathophysiology of major depressive disorder (MDD). However, studies have reported heterogeneous results for changes in neurometabolite levels across brain regions and whether these changes are related to antidepressant intervention. Herein, we performed a meta‐analysis to investigate consistent findings by searching PubMed, Embase, MEDLINE, PsycINFO, and SinoMed from the start date of these databases to May 2023 (PROSPERO#CRD42023405205). Among the 2529 publications screened, 55 studies were included in the meta‐analysis, with 1400 MDD patients and 1322 healthy controls. The results revealed significant decreases in Glx (glutamate + glutamine) in the anterior cingulate cortex (ACC) and prefrontal cortex (PFC), glutamate in the ACC and γ‐aminobutyric acid in the occipital cortex in MDD patients compared with healthy controls. However, changes in neurometabolite levels from pre to posttherapeutic‐intervention in MDD patients were not significant. Heterogeneity was moderate‐to‐high across all neurotransmitters and brain regions. Nonetheless, these findings inform current translation efforts for MDD research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mental Health Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
- Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
- Department of Psychiatry, West China Second University Hospital, Sichuan University, Chengdu, China.
- Department of Urology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Shiwan Tao, Renhao Deng, Menghan Wei, Yunqi Huang, Huan Sun, Shuhan Yang, Shen Li, Chutian Xiao, Mingli Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Tao, S., Deng, R., Wei, M., Huang, Y., Sun, H., Yang, S., Li, S., Xiao, C., & Li, M. (2025). A Meta‐Analysis of Magnetic Resonance Spectroscopy Studies on Glutamatergic Neurometabolite Levels in Major Depressive Disorder. Depression and Anxiety, 2025(1). https://doi.org/10.1155/da/5180077
Vancouver
Tao S, Deng R, Wei M, Huang Y, Sun H, Yang S, et al. A Meta‐Analysis of Magnetic Resonance Spectroscopy Studies on Glutamatergic Neurometabolite Levels in Major Depressive Disorder. Depression and Anxiety. 2025;2025(1). doi:10.1155/da/5180077
BibTeX
@article{Tao2025,
author = {Tao, Shiwan and Deng, Renhao and Wei, Menghan and Huang, Yunqi and Sun, Huan and Yang, Shuhan and Li, Shen and Xiao, Chutian and Li, Mingli},
title = {A Meta‐Analysis of Magnetic Resonance Spectroscopy Studies on Glutamatergic Neurometabolite Levels in Major Depressive Disorder},
journal = {Depression and Anxiety},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/da/5180077}
}
EUVIMED